Abstract
The sleep-wake cycle is a complex process that includes wake (W), non-rapid-eye-movement (NREM) and rapid-eye-movement (REM) sleep. Each phase is regulated by specialized brain structures that, by means of different neurotransmitters, maintain the constant expression of the sleep-wake cycle. Molecules like orexin, serotonin, noradrenaline, histamine, for waking; GABA, adenosine, prostaglandins, for NREM sleep and acetylcholine and glutamate for REM sleep, among other molecules are responsible for the expression and maintenance of each phase. When the endocannabinoid system was being described for the first time, almost three decades ago, oleamide’s sleep promoting properties were highlighted. Nowadays, enough evidence has been cumulated to support the endocannabinoid system role in the sleep-wake cycle regulation. The endocannabinoids oleamide anandamide, and 2-arachidonylglycerol promote NREM and/or REM sleep via the CB1R, thereby making this system a target to treat sleep disorders, such as insomnia.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Amancio-Belmont O, Romano-López A, Ruiz-Contreras AE, Méndez-Díaz M, Prospéro-García O (2017, Sep) From adolescent to elder rats: motivation for palatable food and cannabinoids receptors. Dev Neurobiol 77(8):917–927. https://doi.org/10.1002/dneu.22472
Ashton CH, Moore PB (2011, Oct) Endocannabinoid system dysfunction in mood and related disorders. Acta Psychiatr Scand 124(4):250–261. https://doi.org/10.1111/j.1600-0447.2011.01687.x
Atalay H (2011) Comorbidity of insomnia detected by the Pittsburgh sleep quality index with anxiety, depression and personality disorders. Isr J Psychiatry Relat Sci 48(1):54–59
Augner C (2011, Jun) Associations of subjective sleep quality with depression score, anxiety, physical symptoms and sleep onset latency in students. Cent Eur J Public Health 19(2):115–117
Barratt ES, Beaver W, White R (1974, Feb) The effects of marijuana on human sleep patterns. Biol Psychiatry 8(1):47–54
Basile AS, Hanus L, Mendelson WB (1999, Apr 6) Characterization of the hypnotic properties of oleamide. Neuroreport 10(5):947–951
Borbély AA (1982) A two process model of sleep regulation. Hum Neurobiol 1(3):195–204
Brown CA, Campbell MC, Karimi M, Tabbal SD, Loftin SK, Tian LL, Moerlein SM, Perlmutter JS (2012, Jul) Dopamine pathway loss in nucleus accumbens and ventral tegmental area predicts apathetic behavior in MPTP-lesioned monkeys. Exp Neurol 236(1):190–197. https://doi.org/10.1016/j.expneurol.2012.04.025
Callén L, Moreno E, Barroso-Chinea P, Moreno-Delgado D, Cortés A, Mallol J, Casadó V, Lanciego JL, Franco R, Lluis C, Canela EI, McCormick PJ (2012, Jun 15) Cannabinoid receptors CB1 and CB2 form functional heteromers in brain. J Biol Chem 287(25):20851–20865. https://doi.org/10.1074/jbc.M111.335273
Carlini EA, Cunha JM (1981, Aug-Sep) Hypnotic and antiepileptic effects of cannabidiol. J Clin Pharmacol 21(S1):417S–427S
Castillo PE (2012) Presynaptic LTP and LTD of excitatory and inhibitory synapses. Cold Spring Harb Perspect Biol 4(2):a005728. https://doi.org/10.1101/cshperspect.a005728
Cousens K, DiMascio A (1973, Dec 20) (−) Delta 9 THC as an hypnotic. An experimental study of three dose levels. Psychopharmacologia 33(4):355–364
Cravatt BF, Prospero-Garcia O, Siuzdak G, Gilula NB, Henriksen SJ, Boger DL, Lerner RA (1995, Jun 9) Chemical characterization of a family of brain lipids that induce sleep. Science 268(5216):1506–1509
Devane WA, Dysarz FA, Johnson MR, Melvin LS, Howlett AC (1988) Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol 34(5):605–613
Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, Gibson D, Mandelbaum A, Etinger A, Mechoulam R (1992, Dec 18) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258(5090):1946–1949
Feinberg I, Jones R, Walker J, Cavness C, Floyd T (1976, Jun) Effects of marijuana extract and tetrahydrocannabinol on electroencephalographic sleep patterns. Clin Pharmacol Ther 19(6):782–794
Feinberg I, Jones R, Walker JM, Cavness C, March J (1975, Apr) Effects of high dosage delta-9-tetrahydrocannabinol on sleep patterns in man. Clin Pharmacol Ther 17(4):458–466
Goonawardena AV, Plano A, Robinson L, Ross R, Greig I, Pertwee RG, Hampson RE, Platt B, Riedel G (2015, Apr) Modulation of food consumption and sleep-wake cycle in mice by the neutral CB1 antagonist ABD459. Behav Pharmacol 26(3):289–303. https://doi.org/10.1097/FBP.0000000000000108
Gorelick DA, Goodwin RS, Schwilke E, Schroeder JR, Schwope DM, Kelly DL, Ortemann-Renon C, Bonnet D, Huestis MA (2013, Sep-Oct) Around-the-clock oral THC effects on sleep in male chronic daily cannabis smokers. Am J Addict 22(5):510–514. https://doi.org/10.1111/j.1521-0391.2013.12003.x
Hanlon EC, Tasali E, Leproult R, Stuhr KL, Doncheck E, de Wit H, Hillard CJ, Van Cauter E (2015) Circadian rhythm of circulating levels of the endocannabinoid 2-arachidonoylglycerol. J Clin Endocrinol Metab 100(1):220–226. https://doi.org/10.1210/jc.2014-345
Hernández-Cervantes R, Méndez-Díaz M, Prospéro-García Ó (2017) Morales-Montor CiteImmunoregulatory Role of Cannabinoids during Infectious Disease.J Neuroimmunomodulation 24(4-5):183–199.https://doi.org/10.1159/000481824
Herrera-Solís A, Vásquez KG, Prospéro-García O (2010, Mar) Acute and subchronic administration of anandamide or oleamide increases REM sleep in rats. Pharmacol Biochem Behav 95(1):106–112. https://doi.org/10.1016/j.pbb.2009.12.014
Hofer MA (1976, Mar) The organization of sleep and wakefulness after maternal separation in young rats. Dev Psychobiol 9(2):189–205
Howlett AC (2002, Aug) The cannabinoid receptors. Prostaglandins Other Lipid Mediat 68-69:619–631
Huitrón-Reséndiz S, Gombart L, Cravatt BF, Henriksen SJ (2001, Nov) Effect of oleamide on sleep and its relationship to blood pressure, body temperature, and locomotor activity in rats. Exp Neurol 172(1):235–243
Juszczaka GR, Swiergiela AH (2009, 17 March) Properties of gap junction blockers and their behavioural, cognitive and electrophysiological effects: animal and human studies. Biological Psychiatry 33(2):181–198. https://doi.org/10.1016/j.pnpbp.2008.12.014
Kumar S, Rai S, Hsieh KC, McGinty D, Alam MN, Szymusiak R (2013, Jul 1) Adenosine a(2A) receptors regulate the activity of sleep regulatory GABAergic neurons in the preoptic hypothalamus. Am J Physiol Regul Integr Comp Physiol 305(1):R31–R41. https://doi.org/10.1152/ajpregu.00402.2012
Lambás-Señas L, Mnie-Filali O, Certin V, Faure C, Lemoine L, Zimmer L, Haddjeri N (2009, Mar 17) Functional correlates for 5-HT(1A) receptors in maternally deprived rats displaying anxiety and depression-like behaviors. Prog Neuro-Psychopharmacol Biol Psychiatry 33(2):262–268. https://doi.org/10.1016/j.pnpbp.2008.11.017
Lazarus M, Huang ZL, Lu J, Urade Y, Chen JF (2012, Dec) How do the basal ganglia regulate sleep-wake behavior? Trends Neurosci 35(12):723–732. https://doi.org/10.1016/j.tins.2012.07.001
Lerner RA, Siuzdak G, Prospero-Garcia O, Henriksen SJ, Boger DL, Cravatt BF (1994 Sep 27) Cerebrodiene: a brain lipid isolated from sleep-deprived cats. Proc Natl Acad Sci U S A 91(20):9505–9508
Luppi PH, Fort P (2011) 2011. Neurochemistry of sleep. An overview of animal experimental work. Handb Clin Neurol 98:173–190. https://doi.org/10.1016/B978-0-444-52006-7.00011-3
Martínez-Vargas M, Murillo-Rodríguez E, González-Rivera R, Landa A, Méndez-Díaz M, Prospro-García O, Navarro L (2003) Sleep modulates cannabinoid receptor 1 expression in the pons of rats. Neuroscience 120(3):855–859
Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI (1990, Aug 9) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346(6284):561–564
Mechoulam R, Ben-Shabat S, Hanus L, Ligumsky M, Kaminski NE, Schatz AR, Gopher A, Almog S, Martin BR, Compton DR et al (1995, Jun 29) Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem Pharmacol 50(1):83–90
Mechoulam R, Fride E, Hanus L, Sheskin T, Bisogno T, Di Marzo V, Bayewitch M, Vogel Z (1997, Sep 4) Anandamide may mediate sleep induction. Nature 389(6646):25–26
Mendelson WB, Basile AS (1999, Oct 19) The hypnotic actions of oleamide are blocked by a cannabinoid receptor antagonist. Neuroreport 10(15):3237–3239
Méndez-Díaz M, Caynas-Rojas S, Arteaga Santacruz V, Ruiz-Contreras AE, Aguilar-Roblero R, Prospéro-García O (2013, Jun) Entopeduncular nucleus endocannabinoid system modulates sleep-waking cycle and mood in rats. Pharmacol Biochem Behav 107:29–35. https://doi.org/10.1016/j.pbb.2013.04.003
Munro S, Thomas KL, Abu-Shaar M (1993, Sep 2) Molecular characterization of a peripheral receptor for cannabinoids. Nature 365(6441):61–65
Murillo-Rodriguez E, Blanco-Centurion C, Sanchez C, Piomelli D, Shiromani PJ (2003, Dec 15) Anandamide enhances extracellular levels of adenosine and induces sleep: an in vivo microdialysis study. Sleep 26(8):943–947
Murillo-Rodríguez E, Cabeza R, Méndez-Díaz M, Navarro L, Prospéro-García O (2001, Jul 20) Anandamide-induced sleep is blocked by SR141716A, a CB1 receptor antagonist and by U73122, a phospholipase C inhibitor. Neuroreport 12(10):2131–2136
Murillo-Rodriguez E, Désarnaud F, Prospéro-García O (2006, May 30) Diurnal variation of arachidonoylethanolamine, palmitoylethanolamide and oleoylethanolamide in the brain of the rat. Life Sci 79(1):30–37
Murillo-Rodríguez E, Sánchez-Alavez M, Navarro L, Martínez-González D, Drucker-Colín R, Prospéro-García O (1998). Anandamide modulates sleep and memory in ratsBrain Res. 812(1-2):270–4. https://doi.org/10.1016/s0006-8993(98)00969-x
Navarro L, Martínez-vargas M, Murillo-rodríguez E, Landa A, Méndez-díaz M, Prospéro-garcía O (2003) Potential role of the cannabinoid receptor CB1 in rapid eye movement sleep rebound. Neuroscience 120(3):855–859
Nicholson AN, Turner C, Stone BM, Robson PJ (2004, Jun) Effect of Delta-9-tetrahydrocannabinol and cannabidiol on nocturnal sleep and early-morning behavior in young adults. J Clin Psychopharmacol 24(3):305–313
Pérez-Morales M, Alvarado-Capuleño I, López-Colomé AM, Méndez-Díaz M, Ruiz-Contreras AE, Prospéro-García O (2012, Oct 3) Activation of PAR1 in the lateral hypothalamus of rats enhances food intake and REMS through CB1R. Neuroreport 23(14):814–818. https://doi.org/10.1097/WNR.0b013e328357615a
Pérez-Morales M, Fajardo-Valdez A, Méndez-Díaz M, Ruiz-Contreras AE, Prospéro-García O (2014, Dec 17) 2-Arachidonoylglycerol into the lateral hypothalamus improves reduced sleep in adult rats subjected to maternal separation. Neuroreport 25(18):1437–1441. https://doi.org/10.1097/WNR.0000000000000287
Pérez-Morales M, De La Herrán-Arita AK, Méndez-Díaz M, Ruiz-Contreras AE, Drucker-Colín R, Prospéro-García O (2013, Jul) 2-AG into the lateral hypothalamus increases REM sleep and cFos expression in melanin concentrating hormone neurons in rats. Pharmacol Biochem Behav 108:1–7. https://doi.org/10.1016/j.pbb.2013.04.006
Pivik RT, Zarcone V, Dement WC, Hollister LE (1972, May-Jun) Delta-9-tetrahydrocannabinol and synhexl: effects on human sleep patterns. Clin Pharmacol Ther 13(3):426–435
Porkka-Heiskanen T, Strecker RE, McCarley RW (2000) Brain site-specificity of extracellular adenosine concentration changes during sleep deprivation and spontaneous sleep: an in vivo microdialysis study. Neuroscience 99(3):507–517
Prospéro-García O, Amancio-Belmont O, Becerril Meléndez AL, Ruiz-Contreras AE, Méndez-Díaz M (2016, Dec) Endocannabinoids and sleep. Neurosci Biobehav Rev 71:671–679. https://doi.org/10.1016/j.neubiorev.2016.10.005
Reyes Prieto NM, Romano López A, Pérez Morales M, Pech O, Méndez-Díaz M, Ruiz Contreras AE, Prospéro-García O (2012, Dec) Oleamide restores sleep in adult rats that were subjected to maternal separation. Pharmacol Biochem Behav 103(2):308–312. https://doi.org/10.1016/j.pbb.2012.08.028
Rinaldi-Carmona M, Barth F, Héaulme M, Shire D, Calandra B, Congy C, Martinez S, Maruani J, Néliat G, Caput D et al (1994 Aug 22) SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett 350(2–3):240–244
Romano-López A, Méndez-Díaz M, Ruiz-Contreras AE, Carrisoza R, Prospéro-García O (2012, Oct 25) Maternal separation and proclivity for ethanol intake: a potential role of the endocannabinoid system in rats. Neuroscience 223:296–304. https://doi.org/10.1016/j.neuroscience.2012.07.071
Rueda-Orozco PE, Montes-Rodriguez CJ, Ruiz-Contreras AE, Mendez-Diaz M, Prospero-Garcia O (2017, Oct 1) The effects of anandamide and oleamide on cognition depend on diurnal variations. Brain Res 1672:129–136. https://doi.org/10.1016/j.brainres.2017.08.002
Sanford AE, Castillo E, Gannon RL (2008, Jul 30) Cannabinoids and hamster circadian activity rhythms. Brain Res 1222:141–148. https://doi.org/10.1016/j.brainres.2008.05.048
Santucci V, Storme JJ, Soubrié P, Le Fur G (1996) Arousal-enhancing properties of the CB1 cannabinoid receptor antagonist SR 141716A in rats as assessed by electroencephalographic spectral and sleep-waking cycle analysis. Life Sci 58(6):PL103–PL110
Siegel JM (2009, Sep) The neurobiology of sleep. emin Neurol 29(4):277–296. https://doi.org/10.1055/s-0029-1237118
Takao K, Noguchi K, Hashimoto Y, Shirahata A, Sugita Y (2015) Synthesis and evaluation of fatty acid amides on the N-oleoylethanolamide-like activation of peroxisome proliferator activated receptor α. Chem Pharm Bull (Tokyo) 63(4):278–285. https://doi.org/10.1248/cpb.c14-00881
Terry GE, Liow JS, Zoghbi SS, Hirvonen J, Farris AG, Lerner A, Tauscher JT, Schaus JM, Phebus L, Felder CC, Morse CL, Hong JS, Pike VW, Halldin C, Innis RB (2009). Quantitation ofcannabinoid CB1 receptors in healthy human brain using positron emission tomography and an inverse agonist radioligand Neuroimage. 48(2):362–70.https://doi.org/10.1016/j.neuroimage
Valenti M, Viganò D, Casico MG, Rubino T, Steardo L, Parolaro D, Di Marzo V (2004, Apr) Differential diurnal variations of anandamide and 2-arachidonoyl-glycerol levels in rat brain. Cell Mol Life Sci 61(7–8):945–950
Vaughn LK, Denning G, Stuhr KL, de Wit H, Hill MN, Hillard CJ (2010, Jun) Endocannabinoid signalling: has it got rhythm? Br J Pharmacol 160(3):530–543. https://doi.org/10.1111/j.1476-5381.2010.00790.x
Xi ZX, Peng XQ, Li X, Song R, Zhang HY, Liu QR, Yang HJ, Bi GH, Li J, Gardner EL (2011, Jul 24) Brain cannabinoid CB2 receptors modulate cocaine's actions in mice. Nat Neurosci 14(9):1160–1166. https://doi.org/10.1038/nn.2874
Zuardi AW (2008, Sep) Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action. Rev Bras Psiquiatr 30(3):271–280
Acknowledgments
Work referred here has been supported by Grants IN218620, IA205218, and IN217918 from DGAPA-UNAM to OPG, MMD, and AERC, respectively.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Méndez-Díaz, M., Ruiz-Contreras, A.E., Cortés-Morelos, J., Prospéro-García, O. (2021). Cannabinoids and Sleep/Wake Control. In: Monti, J.M., Pandi-Perumal, S.R., Murillo-Rodríguez, E. (eds) Cannabinoids and Sleep. Advances in Experimental Medicine and Biology, vol 1297. Springer, Cham. https://doi.org/10.1007/978-3-030-61663-2_6
Download citation
DOI: https://doi.org/10.1007/978-3-030-61663-2_6
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-61662-5
Online ISBN: 978-3-030-61663-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)